GH Research PLC (GHRS) stock
GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.25−0.02 (-0.11%)
Close on Nov 18, 2026Market cap $1.13BP/E –Yield –
GH Research operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
GH Research's operating cash flow for the twelve months ending Jun 30, 2026 was -$51.70M. For fiscal 2025 it was -$43.55M. The highest annual figure on record is -$289.00K in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$43.55M | – |
| FY2024 | Dec 31, 2024 | -$42.29M | – |
| FY2023 | Dec 31, 2023 | -$33.34M | – |
| FY2022 | Dec 31, 2022 | -$26.20M | – |
| FY2021 | Dec 31, 2021 | -$15.28M | – |
| FY2020 | Dec 31, 2020 | -$330.00K | – |
| FY2019 | Dec 31, 2019 | -$289.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.02M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.67M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.33M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.68M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.97M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.57M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.45M | – |
| Q3 FY2024 | Sep 30, 2024 | -$12.31M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.60M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.09M | – |
| Q3 FY2023 | Sep 30, 2023 | -$10.34M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.03M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.89M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.87M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.05M | – |
See a number that looks wrong?